PPIs: reviewing treatment for gastro-oesophageal reflux disease
How would you advise a patient with well-controlled gastro-oesophageal reflux disease (GORD) who would like to continue their proton pump inhibitor (PPI) therapy?
Neuropathic pain: a roadmap for diagnosis and management
Improve patient outcomes by using a stepwise approach to diagnosing neuropathic pain, and discover emerging evidence for first-line medicines.
Statins: who, when and how?
Review your approach to the use of statins in the context of cardiovascular (CV) risk, and the assessment and management of suspected statin-associated muscle symptoms.
Osteoarthritis: practical tools for management
How can you help patients put into practice non-pharmacological approaches to managing their knee osteoarthritis (OA)?
Rheumatoid arthritis: getting the facts straight about methotrexate
Optimal management of patients with rheumatoid arthritis depends on successful collaboration between rheumatologists, GPs and community pharmacists.
CV risk in patients with type 2 diabetes and CVD: getting to the heart of diabetes
Listen to our multidisciplinary panel of experts as they discuss the prevention of CV events in patients with both type 2 diabetes and CVD.
Statins: optimising therapy
How do we optimise a patient’s statin therapy for the management of dyslipidaemia with minimal side effects?
Real-time prescription monitoring (SafeScript)
A series of three modules to train prescribers and pharmacists on the use of the SafeScript system.
Access is restricted to health practitioners in Victoria.